Success Stories: EB-1A Approved for Postdoctoral Research Scholar in California in the Field of Pharmaceutical Sciences
Client’s Testimonial:
Thank you so much for this news, I am very happy. This wouldn't have been possible without your help.
Position at the Time of Case Filing: Postdoctoral Research Scholar
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: September 12th, 2014
Processing Time: 4 Months, 26 Days
This case offered North American Immigration Law Group the opportunity to work with a postdoctoral research scholar of pharmaceutical sciences from India. Her research was conducted on the specialized topic of brain-penetrating biologics for the treatment of neurological conditions such as Alzheimer’s disease and stroke. We intended to prove that our client qualified for classification as an Alien of Extraordinary Ability and should be permitted to remain in the United States to continue work in the area of extraordinary ability. She had produced 12 peer-reviewed scientific articles; at the time we filed her case, these publications had received at least 85 citations from independent and leading researchers at prestigious institutions, showing the great significance of her work. Additionally, she had reviewed 18 manuscripts for internationally-circulated and respected journals. Her exceptional level of expertise was corroborated by an independent recommender: “The reason I find this work to be a telling signal of [Client’s] high quality is that it has such practical implications for the treatment of stroke. Strokes are quite deadly, and quite expensive to treat in survivors. Any new methodology for understanding strokes is thus beneficial in financial and humanistic terms. Thanks to [Client], we now know that intracerebral microdialysis can continuously monitor BBB [blood-brain barrier] permeability changes, and therefore we now have access to a great quantity of data with which we can develop new and better stroke therapies.” We sought to show that our client’s continued research would substantially and prospectively benefit the United States, through the extensive documentation and proof that we submitted. Our client’s case was approved in four months and twenty-six days.